Global Patient Derived Xenograft/PDX Models Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.com

DUBLIN--()--The "Patient Derived Xenograft/PDX Models - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The Patient Derived Xenograft/PDX Models market worldwide is projected to grow by US$176.1 Million, driven by a compounded growth of 17.1%.

Mouse, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$178 Million by the year 2025, Mouse will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 18.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$6.9 Million to the region's size and clout in the next 5 to 6 years. Over US$8.4 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Mouse will reach a market size of US$12.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.8% over the next couple of years and add approximately US$31 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:

  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Epo Berlin-Buch GmbH
  • Hera BioLabs
  • Oncodesign
  • Pharmatest Services Ltd.
  • The Jackson Laboratory
  • Urolead SAS
  • WuXi AppTec
  • Xentech

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Patient Derived Xenograft/PDX Models Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
  • US Patient Derived Xenograft/PDX Models Market Share (in %) by Company: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

  • Market Facts & Figures
  • European Patient Derived Xenograft/PDX Models Market: Competitor Market Share Scenario (in %) for 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

REST OF EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/ef68ux

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900